Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide.
Oka T, Hatano K, Tani M, Yoshimura A, Horibe Y, Liu Y, Sassi N, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Ishizuya YU, Yamamoto Y, Kato T, Kawashima A, Fujita K, Nonomura N. Oka T, et al. Among authors: nonomura n. Cancer Diagn Progn. 2024 Nov 3;4(6):706-714. doi: 10.21873/cdp.10385. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502601 Free PMC article.
The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.
Oka T, Hatano K, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Tomiyama E, Ishizuya Y, Yamamoto Y, Kato T, Kawashima A, Fujita K, Nonomura N. Oka T, et al. Among authors: nonomura n. Int J Clin Oncol. 2023 Mar;28(3):427-435. doi: 10.1007/s10147-022-02288-5. Epub 2022 Dec 29. Int J Clin Oncol. 2023. PMID: 36580184
Urinary biomarkers of prostate cancer.
Fujita K, Nonomura N. Fujita K, et al. Among authors: nonomura n. Int J Urol. 2018 Sep;25(9):770-779. doi: 10.1111/iju.13734. Epub 2018 Aug 21. Int J Urol. 2018. PMID: 30129068 Review.
Role of Androgen Receptor in Prostate Cancer: A Review.
Fujita K, Nonomura N. Fujita K, et al. Among authors: nonomura n. World J Mens Health. 2019 Sep;37(3):288-295. doi: 10.5534/wjmh.180040. Epub 2018 Sep 10. World J Mens Health. 2019. PMID: 30209899 Free PMC article. Review.
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer.
Ishizuya Y, Uemura M, Narumi R, Tomiyama E, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Imamura R, Adachi J, Tomonaga T, Nonomura N. Ishizuya Y, et al. Among authors: nonomura n. Biochem Biophys Res Commun. 2020 Mar 12;523(3):588-594. doi: 10.1016/j.bbrc.2019.12.084. Epub 2020 Jan 12. Biochem Biophys Res Commun. 2020. PMID: 31941606 Free article.
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C, Uemura M, Tomiyama E, Matsushita M, Koh Y, Nakano K, Hayashi Y, Ishizuya Y, Jingushi K, Kato T, Hatano K, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Tsujikawa K, Nonomura N. Wang C, et al. Among authors: nonomura n. Cancer Sci. 2020 Apr;111(4):1146-1155. doi: 10.1111/cas.14325. Epub 2020 Feb 19. Cancer Sci. 2020. PMID: 31975504 Free PMC article.
Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer.
Fujita K, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Okihara K, Ukimura O, Miki T, Nakajima T, Kaneda Y, Nonomura N. Fujita K, et al. Among authors: nonomura n. Cancer Sci. 2020 May;111(5):1692-1698. doi: 10.1111/cas.14366. Epub 2020 Mar 19. Cancer Sci. 2020. PMID: 32112659 Free PMC article. Clinical Trial.
679 results